Simon Hambidge
Concepts (328)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vaccination | 35 | 2023 | 1204 | 2.860 |
Why?
| Vaccines | 18 | 2024 | 375 | 2.720 |
Why?
| Influenza Vaccines | 20 | 2023 | 497 | 2.680 |
Why?
| Immunization | 8 | 2021 | 397 | 2.100 |
Why?
| Influenza, Human | 15 | 2023 | 546 | 1.920 |
Why?
| Pediatric Obesity | 10 | 2024 | 489 | 1.700 |
Why?
| Immunization Programs | 10 | 2022 | 205 | 1.660 |
Why?
| Adverse Drug Reaction Reporting Systems | 10 | 2023 | 68 | 1.370 |
Why?
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 10 | 2017 | 89 | 1.130 |
Why?
| Infant | 52 | 2022 | 7964 | 1.130 |
Why?
| Parents | 8 | 2021 | 1186 | 1.080 |
Why?
| Child Health Services | 5 | 2022 | 176 | 1.070 |
Why?
| Measles-Mumps-Rubella Vaccine | 9 | 2021 | 41 | 1.060 |
Why?
| Child, Preschool | 48 | 2022 | 9118 | 1.050 |
Why?
| Terminology as Topic | 2 | 2017 | 187 | 0.960 |
Why?
| Chickenpox Vaccine | 9 | 2021 | 69 | 0.930 |
Why?
| Attitude to Health | 3 | 2017 | 406 | 0.910 |
Why?
| Cohort Studies | 37 | 2023 | 4895 | 0.840 |
Why?
| Managed Care Programs | 5 | 2017 | 133 | 0.790 |
Why?
| Counseling | 3 | 2017 | 342 | 0.790 |
Why?
| Government Programs | 1 | 2021 | 22 | 0.740 |
Why?
| Female | 87 | 2024 | 59521 | 0.740 |
Why?
| Colorado | 19 | 2017 | 4100 | 0.730 |
Why?
| Immunization Schedule | 5 | 2021 | 184 | 0.730 |
Why?
| Child | 50 | 2024 | 18420 | 0.730 |
Why?
| Information Storage and Retrieval | 3 | 2020 | 106 | 0.690 |
Why?
| Vaccines, Combined | 5 | 2020 | 46 | 0.680 |
Why?
| Male | 70 | 2024 | 55607 | 0.670 |
Why?
| Humans | 112 | 2024 | 114705 | 0.670 |
Why?
| Reminder Systems | 2 | 2013 | 160 | 0.660 |
Why?
| Whooping Cough | 5 | 2014 | 49 | 0.660 |
Why?
| Adolescent | 43 | 2021 | 17853 | 0.660 |
Why?
| Language | 4 | 2017 | 263 | 0.650 |
Why?
| Population Surveillance | 9 | 2017 | 392 | 0.630 |
Why?
| United States | 41 | 2023 | 12186 | 0.620 |
Why?
| Preventive Health Services | 2 | 2013 | 135 | 0.620 |
Why?
| Anemia, Sickle Cell | 2 | 2011 | 215 | 0.620 |
Why?
| Wounds and Injuries | 4 | 2008 | 749 | 0.600 |
Why?
| Seizures, Febrile | 5 | 2017 | 19 | 0.600 |
Why?
| Pneumococcal Vaccines | 3 | 2022 | 131 | 0.590 |
Why?
| Urban Population | 5 | 2016 | 397 | 0.590 |
Why?
| School Health Services | 4 | 2014 | 206 | 0.560 |
Why?
| Vulnerable Populations | 2 | 2009 | 134 | 0.550 |
Why?
| Seizures | 3 | 2014 | 340 | 0.530 |
Why?
| Safety-net Providers | 4 | 2021 | 95 | 0.530 |
Why?
| Body Mass Index | 6 | 2024 | 1959 | 0.520 |
Why?
| Emergency Service, Hospital | 6 | 2014 | 1820 | 0.510 |
Why?
| Pregnancy Complications, Infectious | 5 | 2022 | 288 | 0.510 |
Why?
| Dental Caries | 1 | 2017 | 162 | 0.500 |
Why?
| Retrospective Studies | 35 | 2024 | 12556 | 0.500 |
Why?
| Oral Health | 1 | 2017 | 140 | 0.490 |
Why?
| Hospitalization | 6 | 2020 | 1752 | 0.480 |
Why?
| Chickenpox | 2 | 2020 | 93 | 0.480 |
Why?
| Office Visits | 2 | 2007 | 79 | 0.460 |
Why?
| Incidence | 17 | 2022 | 2313 | 0.460 |
Why?
| Home Care Services, Hospital-Based | 1 | 2014 | 10 | 0.460 |
Why?
| Primary Health Care | 6 | 2021 | 1514 | 0.460 |
Why?
| Abortion, Spontaneous | 3 | 2023 | 90 | 0.440 |
Why?
| Papillomavirus Vaccines | 1 | 2016 | 223 | 0.440 |
Why?
| Product Surveillance, Postmarketing | 6 | 2022 | 63 | 0.430 |
Why?
| Pregnancy | 21 | 2023 | 5520 | 0.430 |
Why?
| Pertussis Vaccine | 2 | 2011 | 21 | 0.420 |
Why?
| Bronchiolitis | 1 | 2014 | 81 | 0.420 |
Why?
| Oxygen Inhalation Therapy | 1 | 2014 | 129 | 0.410 |
Why?
| Genes, MHC Class II | 1 | 2012 | 69 | 0.410 |
Why?
| Young Adult | 23 | 2021 | 10471 | 0.410 |
Why?
| Weight Reduction Programs | 2 | 2024 | 94 | 0.410 |
Why?
| Infant, Newborn | 17 | 2019 | 5047 | 0.400 |
Why?
| Delivery of Health Care | 2 | 2017 | 833 | 0.400 |
Why?
| Health Promotion | 2 | 2023 | 686 | 0.400 |
Why?
| Treatment Refusal | 2 | 2010 | 85 | 0.390 |
Why?
| Case-Control Studies | 12 | 2016 | 3003 | 0.390 |
Why?
| Health Personnel | 1 | 2017 | 574 | 0.380 |
Why?
| Rotavirus Vaccines | 3 | 2022 | 48 | 0.380 |
Why?
| Health Services Research | 2 | 2012 | 371 | 0.380 |
Why?
| Vaccination Coverage | 2 | 2022 | 63 | 0.360 |
Why?
| Vaccines, Inactivated | 4 | 2012 | 68 | 0.360 |
Why?
| Pneumonia, Pneumococcal | 1 | 2010 | 38 | 0.350 |
Why?
| Communication Barriers | 1 | 2011 | 89 | 0.350 |
Why?
| Adult | 32 | 2023 | 30553 | 0.350 |
Why?
| Risk Assessment | 12 | 2020 | 2968 | 0.350 |
Why?
| Health Services Accessibility | 4 | 2011 | 763 | 0.350 |
Why?
| Meningococcal Vaccines | 3 | 2017 | 48 | 0.350 |
Why?
| Urban Health | 2 | 2006 | 73 | 0.330 |
Why?
| Case Management | 1 | 2009 | 62 | 0.320 |
Why?
| Mucocutaneous Lymph Node Syndrome | 2 | 2022 | 76 | 0.310 |
Why?
| Congenital Abnormalities | 3 | 2017 | 73 | 0.300 |
Why?
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2008 | 12 | 0.300 |
Why?
| Insurance, Health | 3 | 2012 | 244 | 0.300 |
Why?
| Pediatrics | 2 | 2006 | 981 | 0.300 |
Why?
| Child Development | 1 | 2011 | 385 | 0.280 |
Why?
| Poverty | 5 | 2021 | 442 | 0.280 |
Why?
| Internet | 1 | 2011 | 596 | 0.280 |
Why?
| Measles | 2 | 2020 | 38 | 0.280 |
Why?
| Child Care | 1 | 2007 | 23 | 0.280 |
Why?
| Community Health Services | 2 | 2010 | 212 | 0.270 |
Why?
| Accident Prevention | 1 | 2006 | 24 | 0.270 |
Why?
| Electronic Health Records | 5 | 2023 | 800 | 0.270 |
Why?
| Anaphylaxis | 3 | 2021 | 143 | 0.270 |
Why?
| Risk | 9 | 2017 | 812 | 0.260 |
Why?
| Middle Aged | 18 | 2021 | 26738 | 0.260 |
Why?
| Mass Screening | 2 | 2015 | 1006 | 0.260 |
Why?
| Chorioamnionitis | 2 | 2017 | 36 | 0.250 |
Why?
| Diphtheria-Tetanus-Pertussis Vaccine | 2 | 2017 | 25 | 0.250 |
Why?
| Herpes Zoster | 2 | 2020 | 331 | 0.250 |
Why?
| International Classification of Diseases | 2 | 2020 | 116 | 0.250 |
Why?
| Developmental Disabilities | 2 | 2020 | 237 | 0.250 |
Why?
| Aluminum | 2 | 2022 | 34 | 0.240 |
Why?
| Patient Acceptance of Health Care | 5 | 2024 | 681 | 0.240 |
Why?
| Athletic Injuries | 3 | 2006 | 456 | 0.240 |
Why?
| Prenatal Care | 2 | 2017 | 253 | 0.230 |
Why?
| Pregnant Women | 2 | 2022 | 131 | 0.220 |
Why?
| Insurance, Health, Reimbursement | 2 | 2014 | 88 | 0.220 |
Why?
| Healthcare Disparities | 2 | 2021 | 480 | 0.210 |
Why?
| Smallpox Vaccine | 1 | 2022 | 22 | 0.210 |
Why?
| Delivery of Health Care, Integrated | 3 | 2021 | 228 | 0.210 |
Why?
| Drug-Related Side Effects and Adverse Reactions | 3 | 2022 | 238 | 0.210 |
Why?
| Multivariate Analysis | 4 | 2015 | 1430 | 0.210 |
Why?
| Bell Palsy | 1 | 2022 | 6 | 0.200 |
Why?
| Cataplexy | 1 | 2022 | 6 | 0.200 |
Why?
| Narcolepsy | 1 | 2022 | 19 | 0.200 |
Why?
| Risk Factors | 8 | 2020 | 8632 | 0.200 |
Why?
| Thrombocytopenia | 2 | 2022 | 177 | 0.200 |
Why?
| Motivation | 2 | 2017 | 494 | 0.200 |
Why?
| Pregnancy Complications | 3 | 2017 | 429 | 0.190 |
Why?
| Pneumococcal Infections | 1 | 2022 | 91 | 0.190 |
Why?
| Eczema | 1 | 2022 | 81 | 0.190 |
Why?
| Focus Groups | 2 | 2014 | 383 | 0.190 |
Why?
| Fever | 2 | 2013 | 280 | 0.180 |
Why?
| Australia | 1 | 2020 | 206 | 0.170 |
Why?
| Vaccination Refusal | 1 | 2021 | 69 | 0.170 |
Why?
| Mumps | 1 | 2020 | 23 | 0.170 |
Why?
| Diphtheria-Tetanus Vaccine | 2 | 2009 | 4 | 0.170 |
Why?
| Age Distribution | 4 | 2010 | 342 | 0.160 |
Why?
| Sex Distribution | 4 | 2010 | 337 | 0.160 |
Why?
| Tetanus Toxoid | 2 | 2015 | 37 | 0.160 |
Why?
| Regression Analysis | 4 | 2015 | 945 | 0.150 |
Why?
| Cross-Sectional Studies | 5 | 2009 | 4410 | 0.150 |
Why?
| Practice Patterns, Physicians' | 1 | 2006 | 1177 | 0.150 |
Why?
| Prevalence | 4 | 2020 | 2251 | 0.150 |
Why?
| Community Health Centers | 2 | 2009 | 54 | 0.150 |
Why?
| Premature Birth | 3 | 2017 | 276 | 0.150 |
Why?
| Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | 1 | 2017 | 15 | 0.150 |
Why?
| Syncope | 1 | 2017 | 37 | 0.140 |
Why?
| Infant, Small for Gestational Age | 2 | 2015 | 76 | 0.140 |
Why?
| Diagnosis, Oral | 1 | 2017 | 6 | 0.140 |
Why?
| Paint | 1 | 2017 | 7 | 0.140 |
Why?
| Dentists | 1 | 2017 | 19 | 0.140 |
Why?
| Age Factors | 5 | 2017 | 2894 | 0.140 |
Why?
| Confidence Intervals | 3 | 2021 | 305 | 0.140 |
Why?
| Fluorides | 1 | 2017 | 43 | 0.140 |
Why?
| Preconception Care | 1 | 2017 | 31 | 0.140 |
Why?
| Uterine Cervical Dysplasia | 1 | 2017 | 42 | 0.140 |
Why?
| Logistic Models | 3 | 2015 | 1841 | 0.140 |
Why?
| Registries | 4 | 2010 | 1768 | 0.140 |
Why?
| Drug Hypersensitivity | 1 | 2017 | 83 | 0.130 |
Why?
| Aged | 6 | 2021 | 19074 | 0.130 |
Why?
| Phosphates | 1 | 2017 | 159 | 0.130 |
Why?
| Time Factors | 9 | 2022 | 6116 | 0.130 |
Why?
| Educational Status | 2 | 2023 | 412 | 0.130 |
Why?
| Sex Factors | 2 | 2021 | 1715 | 0.130 |
Why?
| Telemedicine | 1 | 2024 | 662 | 0.130 |
Why?
| Infant, Newborn, Diseases | 1 | 2017 | 104 | 0.130 |
Why?
| Pneumonia, Viral | 1 | 2020 | 338 | 0.120 |
Why?
| Coronavirus Infections | 1 | 2020 | 330 | 0.120 |
Why?
| Seasons | 4 | 2022 | 442 | 0.120 |
Why?
| Causality | 2 | 2006 | 103 | 0.120 |
Why?
| Health Care Surveys | 2 | 2007 | 539 | 0.120 |
Why?
| Pandemics | 4 | 2024 | 1320 | 0.120 |
Why?
| Computer Simulation | 3 | 2013 | 873 | 0.120 |
Why?
| Hypertension, Pregnancy-Induced | 1 | 2014 | 45 | 0.110 |
Why?
| Parental Consent | 1 | 2014 | 22 | 0.110 |
Why?
| Papillomavirus Infections | 1 | 2017 | 261 | 0.110 |
Why?
| Predictive Value of Tests | 3 | 2009 | 1796 | 0.110 |
Why?
| Poliovirus Vaccine, Inactivated | 1 | 2014 | 22 | 0.110 |
Why?
| Patient Navigation | 1 | 2015 | 64 | 0.110 |
Why?
| Fruit | 1 | 2015 | 127 | 0.110 |
Why?
| Vegetables | 1 | 2015 | 133 | 0.110 |
Why?
| Reimbursement Mechanisms | 1 | 2014 | 77 | 0.110 |
Why?
| Bacterial Vaccines | 1 | 2014 | 61 | 0.110 |
Why?
| Social Environment | 1 | 2015 | 283 | 0.110 |
Why?
| Comprehension | 1 | 2014 | 156 | 0.110 |
Why?
| Follow-Up Studies | 5 | 2021 | 4411 | 0.110 |
Why?
| Health Policy | 1 | 2016 | 334 | 0.110 |
Why?
| Databases, Factual | 2 | 2015 | 1125 | 0.100 |
Why?
| Drug Eruptions | 1 | 2013 | 26 | 0.100 |
Why?
| Viral Vaccines | 1 | 2014 | 88 | 0.100 |
Why?
| Infant, Premature, Diseases | 1 | 2014 | 89 | 0.100 |
Why?
| Utilization Review | 2 | 2009 | 34 | 0.100 |
Why?
| Qualitative Research | 1 | 2017 | 936 | 0.100 |
Why?
| Rotavirus Infections | 2 | 2012 | 50 | 0.100 |
Why?
| Socioeconomic Factors | 2 | 2006 | 1079 | 0.100 |
Why?
| Pregnancy Outcome | 3 | 2023 | 337 | 0.100 |
Why?
| Immunization, Secondary | 2 | 2009 | 82 | 0.100 |
Why?
| Maternal Age | 2 | 2023 | 117 | 0.100 |
Why?
| Health Services | 1 | 2013 | 103 | 0.100 |
Why?
| Intussusception | 1 | 2012 | 27 | 0.100 |
Why?
| Parenting | 1 | 2015 | 252 | 0.100 |
Why?
| Health Education | 1 | 2015 | 323 | 0.100 |
Why?
| Models, Theoretical | 2 | 2013 | 515 | 0.100 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2017 | 452 | 0.100 |
Why?
| Gastrointestinal Diseases | 1 | 2013 | 182 | 0.090 |
Why?
| Electronic Mail | 1 | 2011 | 54 | 0.090 |
Why?
| Longitudinal Studies | 2 | 2014 | 2387 | 0.090 |
Why?
| Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2010 | 11 | 0.090 |
Why?
| Database Management Systems | 1 | 2011 | 47 | 0.090 |
Why?
| Health Care Costs | 1 | 2014 | 381 | 0.090 |
Why?
| Altitude | 1 | 2014 | 432 | 0.090 |
Why?
| Asthma | 1 | 2022 | 2029 | 0.080 |
Why?
| Hepatitis A Vaccines | 1 | 2009 | 15 | 0.080 |
Why?
| Diphtheria Toxoid | 1 | 2009 | 12 | 0.080 |
Why?
| Hepatitis B Vaccines | 1 | 2009 | 46 | 0.080 |
Why?
| Models, Statistical | 1 | 2013 | 599 | 0.080 |
Why?
| Patient Readmission | 1 | 2014 | 610 | 0.080 |
Why?
| Medicaid | 2 | 2009 | 407 | 0.080 |
Why?
| Acetaminophen | 1 | 2011 | 241 | 0.080 |
Why?
| Drug Evaluation | 1 | 2008 | 77 | 0.080 |
Why?
| Purpura, Thrombocytopenic | 1 | 2008 | 5 | 0.080 |
Why?
| Ambulatory Care Facilities | 2 | 2009 | 213 | 0.080 |
Why?
| Gastroenteritis | 1 | 2009 | 65 | 0.080 |
Why?
| House Calls | 1 | 2009 | 115 | 0.070 |
Why?
| Acute Disease | 2 | 2008 | 911 | 0.070 |
Why?
| Platelet Count | 1 | 2008 | 81 | 0.070 |
Why?
| Splenectomy | 1 | 2008 | 52 | 0.070 |
Why?
| Communicable Disease Control | 1 | 2008 | 67 | 0.070 |
Why?
| Probability | 1 | 2008 | 289 | 0.070 |
Why?
| Hypersensitivity | 1 | 2011 | 252 | 0.070 |
Why?
| Vaccines, Conjugate | 2 | 2022 | 59 | 0.070 |
Why?
| Health Surveys | 1 | 2009 | 443 | 0.070 |
Why?
| Multicenter Studies as Topic | 1 | 2008 | 249 | 0.070 |
Why?
| Social Class | 1 | 2008 | 204 | 0.070 |
Why?
| Severity of Illness Index | 3 | 2010 | 2540 | 0.070 |
Why?
| Chronic Disease | 2 | 2013 | 1578 | 0.070 |
Why?
| Skin | 1 | 2011 | 655 | 0.070 |
Why?
| Domestic Violence | 1 | 2006 | 41 | 0.070 |
Why?
| Cluster Analysis | 2 | 2006 | 455 | 0.070 |
Why?
| Disease Progression | 2 | 2014 | 2380 | 0.060 |
Why?
| Patient Dropouts | 1 | 2006 | 66 | 0.060 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2021 | 3252 | 0.060 |
Why?
| Linear Models | 1 | 2008 | 768 | 0.060 |
Why?
| Attitude of Health Personnel | 1 | 2012 | 975 | 0.060 |
Why?
| Brain Ischemia | 1 | 2009 | 299 | 0.060 |
Why?
| Prospective Studies | 4 | 2021 | 6220 | 0.060 |
Why?
| Research Design | 2 | 2013 | 928 | 0.060 |
Why?
| Analysis of Variance | 1 | 2008 | 1226 | 0.060 |
Why?
| Medication Adherence | 1 | 2009 | 536 | 0.060 |
Why?
| Survival Analysis | 1 | 2008 | 1211 | 0.060 |
Why?
| Pregnancy Trimester, First | 2 | 2017 | 125 | 0.060 |
Why?
| Accidents, Home | 1 | 2004 | 28 | 0.060 |
Why?
| Vaccines, Attenuated | 2 | 2017 | 112 | 0.060 |
Why?
| Ambulatory Care | 2 | 2013 | 478 | 0.060 |
Why?
| Aged, 80 and over | 2 | 2015 | 6347 | 0.060 |
Why?
| Genetic Predisposition to Disease | 1 | 2012 | 2086 | 0.060 |
Why?
| Physicians | 1 | 2012 | 772 | 0.060 |
Why?
| Hospitals, General | 1 | 2024 | 19 | 0.060 |
Why?
| Health Status | 1 | 2008 | 722 | 0.050 |
Why?
| Physicians, Family | 1 | 2005 | 201 | 0.050 |
Why?
| Public Health Informatics | 1 | 2003 | 7 | 0.050 |
Why?
| Accidents, Traffic | 1 | 2004 | 170 | 0.050 |
Why?
| Physician's Role | 1 | 2005 | 197 | 0.050 |
Why?
| Proportional Hazards Models | 2 | 2021 | 1075 | 0.050 |
Why?
| Respiratory Tract Infections | 1 | 2006 | 319 | 0.050 |
Why?
| Family Practice | 1 | 2007 | 427 | 0.050 |
Why?
| Health Knowledge, Attitudes, Practice | 2 | 2021 | 1183 | 0.050 |
Why?
| Benchmarking | 1 | 2024 | 161 | 0.050 |
Why?
| Odds Ratio | 2 | 2015 | 953 | 0.050 |
Why?
| Thigh | 2 | 2013 | 53 | 0.050 |
Why?
| Algorithms | 2 | 2020 | 1470 | 0.050 |
Why?
| Injections, Intramuscular | 2 | 2013 | 116 | 0.050 |
Why?
| Public Health Surveillance | 1 | 2021 | 61 | 0.050 |
Why?
| Arm | 2 | 2013 | 104 | 0.050 |
Why?
| Vaccines, Synthetic | 1 | 2021 | 124 | 0.050 |
Why?
| Stroke | 1 | 2009 | 1022 | 0.040 |
Why?
| Myocarditis | 1 | 2021 | 93 | 0.040 |
Why?
| Systole | 1 | 2020 | 171 | 0.040 |
Why?
| Prognosis | 1 | 2008 | 3330 | 0.040 |
Why?
| Antigens | 1 | 2021 | 318 | 0.040 |
Why?
| Health Facilities | 1 | 2020 | 72 | 0.040 |
Why?
| Data Interpretation, Statistical | 1 | 2021 | 321 | 0.040 |
Why?
| Poisson Distribution | 2 | 2011 | 71 | 0.040 |
Why?
| Mass Vaccination | 1 | 2019 | 15 | 0.040 |
Why?
| Bias | 2 | 2013 | 179 | 0.040 |
Why?
| Practice Guidelines as Topic | 1 | 2006 | 1395 | 0.040 |
Why?
| Gestational Age | 1 | 2021 | 760 | 0.040 |
Why?
| Birth Weight | 1 | 2021 | 440 | 0.040 |
Why?
| Health Behavior | 2 | 2015 | 704 | 0.040 |
Why?
| Self Report | 1 | 2022 | 696 | 0.040 |
Why?
| Exercise | 2 | 2020 | 1644 | 0.040 |
Why?
| Surveys and Questionnaires | 2 | 2022 | 4624 | 0.040 |
Why?
| Stillbirth | 1 | 2017 | 57 | 0.040 |
Why?
| Antibodies, Viral | 1 | 2020 | 520 | 0.030 |
Why?
| Propensity Score | 1 | 2017 | 224 | 0.030 |
Why?
| RNA, Messenger | 1 | 2023 | 2553 | 0.030 |
Why?
| Referral and Consultation | 1 | 2020 | 635 | 0.030 |
Why?
| Refugees | 1 | 2015 | 54 | 0.030 |
Why?
| Biomarkers, Pharmacological | 1 | 2015 | 26 | 0.030 |
Why?
| Computers | 1 | 2015 | 60 | 0.030 |
Why?
| Video Games | 1 | 2015 | 21 | 0.030 |
Why?
| Demography | 1 | 2015 | 260 | 0.030 |
Why?
| Blood Pressure | 1 | 2020 | 1538 | 0.030 |
Why?
| Television | 1 | 2015 | 72 | 0.030 |
Why?
| Vasculitis | 1 | 2014 | 66 | 0.030 |
Why?
| Contraindications | 1 | 2014 | 85 | 0.030 |
Why?
| Emigrants and Immigrants | 1 | 2015 | 107 | 0.030 |
Why?
| Family Characteristics | 1 | 2015 | 151 | 0.030 |
Why?
| California | 1 | 2014 | 353 | 0.030 |
Why?
| Drug Utilization | 1 | 2013 | 167 | 0.030 |
Why?
| Parent-Child Relations | 1 | 2015 | 235 | 0.030 |
Why?
| Monitoring, Immunologic | 1 | 2011 | 23 | 0.020 |
Why?
| Family | 1 | 2015 | 589 | 0.020 |
Why?
| Overweight | 1 | 2015 | 472 | 0.020 |
Why?
| Sample Size | 1 | 2011 | 112 | 0.020 |
Why?
| Schools | 1 | 2014 | 399 | 0.020 |
Why?
| Placebos | 1 | 2011 | 197 | 0.020 |
Why?
| Safety Management | 1 | 2011 | 109 | 0.020 |
Why?
| Data Collection | 1 | 2013 | 620 | 0.020 |
Why?
| Safety | 1 | 2011 | 298 | 0.020 |
Why?
| Curriculum | 1 | 2015 | 819 | 0.020 |
Why?
| Diet | 1 | 2015 | 1080 | 0.020 |
Why?
| Epidemiologic Methods | 1 | 2008 | 72 | 0.020 |
Why?
| Drug Administration Schedule | 1 | 2009 | 718 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 1 | 2009 | 1842 | 0.010 |
Why?
| Health Care Reform | 1 | 2005 | 92 | 0.010 |
Why?
| Sensitivity and Specificity | 1 | 2008 | 1694 | 0.010 |
Why?
| Health Services Needs and Demand | 1 | 2005 | 243 | 0.010 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2006 | 1214 | 0.010 |
Why?
| Reproducibility of Results | 1 | 2006 | 2765 | 0.010 |
Why?
| Treatment Outcome | 1 | 2009 | 9088 | 0.010 |
Why?
|
|
Hambidge's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|